ArticleJournal of clinical medicine2024

Optimized Treatment of Interleukin (IL-1)-Mediated Autoinflammatory Diseases: Impact of Disease Activity-Based Treatment Adjustments.

Tatjana Welzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.